EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advancements and Challenges in Developing Malaria Vaccines: Targeting Multiple Stages of the Parasite Life Cycle

Rajneesh, Rahul Tiwari, Vishal K Singh, Awnish Kumar, Rohit P Gupta, Akhilesh K Singh, Vibhav Gautam iD, Rajiv Kumar iD

ACS Infectious Diseases · 2023

DOI: 10.1021/acsinfecdis.3c00332 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Infectious Diseases, 2023. Verfasst von Rajneesh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Experimental Medicine & Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India. Hauptthemen laut MEDLINE: Malaria Vaccines, Life Cycle Stages, Plasmodium, Malaria. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 207 Literaturangaben. Gefördert von: Indian Council of Medical Research, Banaras Hindu University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria, caused by Plasmodium species, remains a major global health concern, causing millions of deaths annually. While the introduction of the RTS,S vaccine has shown promise, there is a pressing need for more effective vaccines due to the emergence of drug-resistant parasites and insecticide-resistant vectors. However, the complex life cycle and genetic diversity of the parasite, technical obstacles, limited funding, and the impact of the 2019 pandemic have hindered progress in malaria vaccine development. This review focuses on advancements in malaria vaccine development, particularly the ongoing clinical trials targeting antigens from different stages of the Plasmodium life cycle. Additionally, we discuss the rationale, strategies, and challenges associated with vaccine design, aiming to enhance the immune response and protective efficacy of vaccine candidates. A cost-effective and multistage vaccine could hold the key to controlling and eradicating malaria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malaria VaccinesLife Cycle StagesPlasmodiumMalariaVaccine DevelopmentHumansAnimalsAntigens, ProtozoanClinical Trials as Topic

Stichwörter der Autor:innen

CHMIPlasmodiumRTS,Sclinical trialsimmune responselife-cyclemalariamultivalent vaccinesprotective efficacyvaccine development

Substanzen

Malaria VaccinesAntigens, Protozoan

Autor:innen und Institutionen

  • Centre of Experimental Medicine & Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India.
  • Department of Applied Microbiology, Institute of Science, Banaras Hindu University, Varanasi 221005, India.
  • Faculty of Dental Science, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India.

ORCID-Profile: Vibhav Gautam, Rajiv Kumar

Förderung

  • Indian Council of Medical Research
  • Banaras Hindu University

Zitieren

APA

Rajneesh, Tiwari, R., Singh, V. K., Kumar, A., Gupta, R. P., Singh, A. K., Gautam, V., & Kumar, R. (2023). Advancements and Challenges in Developing Malaria Vaccines: Targeting Multiple Stages of the Parasite Life Cycle. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.3c00332

Vancouver

Rajneesh, Tiwari R, Singh VK, Kumar A, Gupta RP, Singh AK, et al. Advancements and Challenges in Developing Malaria Vaccines: Targeting Multiple Stages of the Parasite Life Cycle. ACS Infectious Diseases. 2023. doi:10.1021/acsinfecdis.3c00332

BibTeX
@article{Rajneesh2023,
  author = {Rajneesh and Tiwari, Rahul and Singh, Vishal K and Kumar, Awnish and Gupta, Rohit P and Singh, Akhilesh K and Gautam, Vibhav and Kumar, Rajiv},
  title = {Advancements and Challenges in Developing Malaria Vaccines: Targeting Multiple Stages of the Parasite Life Cycle},
  journal = {ACS Infectious Diseases},
  year = {2023},
  doi = {10.1021/acsinfecdis.3c00332}
}
Kostenlos starten →